Home›Screener›LEGN›Profile
F
15/100

Legend Biotech

LEGNOncology
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Legend Biotech (LEGN) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[2], including 4 Phase 1[1].

LEGN has 1 Form 4 insider filing recorded at the SEC in the past 30 days[3].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. SEC EDGAR · 0001801198 (2026-04-11) ↗
🔬
Clinical Trials
6
NCT05539430Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer, Pancreatic Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05680922Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07049081Relapsed/Refractory Autoimmune Diseases
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07095075Relapsed/Refractory Autoimmune Diseases
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07100067Relapsed/Refractory Multiple Myeloma(MM)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07331272Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
1 filing
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Oncology)
NUVBNuvation Bio
B
LBPHLongboard Pharmaceuticals
B
SNDXSyndax Pharmaceuticals
C
KURAKura Oncology, Inc.
C
INCYIncyte Corporation
C
Data Provenance
cik1 verified
clinical trial6 verified
insider buy1 verified
trial count2 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR